Integration of Family Planning and HIV Services in Tanzania
HIV Infection, HIV Infections
About this trial
This is an interventional health services research trial for HIV Infection focused on measuring AE, adverse event, AIDS, acquired immunodeficiency syndrome, ALT (SGPT), alanine aminotransferase, ART, antiretroviral therapy, AST (SGOT), aspartate aminotransferase, DCF, data collection forms, DMC, Data Monitoring Committee, FDA, (U.S.) Food and Drug Administration, GCP, Good Clinical Practice guidelines, HB sAg, Hepatitis B surface antigen, ICH, International Conference of Harmonisation, IND, Investigational New Drug Application, IRB, Institutional Review Board, IU, International units, mg, milligram(s), mm3, cubic millimeter(s), PCR, polymerase chain reaction, SAE, serious adverse event, µg, microgram, ULN, upper limit of the normal range, WB, Western Blot, To inform the Ministry of Health strategy for integrating FP and HIV/AIDS Care and Treatment Services in Tanzania, HIV seronegativity
Eligibility Criteria
Inclusion Criteria:
- Female clients of Care & Treatment Clinics with CD4 counts >100, and are WHO Stage I - III. (CTC Clients)
- Care and Treatment providers who provide services to clients (CTC Providers)
- Care and Treatment supervisors who are the immediate in-charge supervisor for the CTC clinic. (CTC supervisor)
- Family Planning providers who provide services to clients. (FP providers)
- Family Planning supervisors who are the immediate in-charge supervisor for the FP clinic. (FP supervisor)
Sites / Locations
- Muhimbili University of Health and Allied Services
Arms of the Study
Arm 1
Experimental
A. Facilitated Referral
Seven key steps carried out by CTC and FP staff to encourage completion of FP referral by CTC.